Forty-nine patients were treated with either 3 x 75 MBq 89Sr or saline as placebo. Analysis of results 1 to 3 years after therapy revealed the ineffectiveness of 89Sr to relieve pain from metastases. Unexpectedly, a higher survival rate was found after Sr application (46% vs 4% after 2 years). Covariate analysis underlines the effect of 89Sr therapy on life expectation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF00254382 | DOI Listing |
Publication Analysis
Top Keywords
double blind
4
blind study
4
study 89-strontium
4
89-strontium therapy
4
therapy skeletal
4
skeletal metastases
4
metastases prostatic
4
prostatic carcinoma
4
carcinoma forty-nine
4
forty-nine patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!